Komipharm International Co., Ltd. (KOSDAQ:041960)

South Korea · Delayed Price · Currency is KRW

9,270.00

-470.00 (-4.83%)

Aug 21, 2026, 3:30 PM KST

Komipharm International Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	53,018	52,465	58,779	42,647	39,801	35,847
Revenue Growth	-3.27%	-10.74%	37.83%	7.15%	11.03%	-3.53%
Gross Profit	18,406	16,911	21,633	12,527	11,316	11,107
Operating Income	1,764	1,960	6,193	-6,273	-3,804	-5,291
Net Income	-2,582	-7,209	13,113	-3,979	-6,514	-4,459
Earnings Per Share	-36.44	-101.91	188.00	-57.00	-93.00	-63.64
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	27,313	27,888	22,448	14,820	10,805	13,929
Total Debt	41,294	40,672	43,839	45,102	38,131	33,422
Net Cash (Debt)	-13,981	-12,785	-21,391	-30,282	-27,327	-19,493
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-197.29	-180.73	-306.68	-431.66	-388.82	-277.38

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	983.65	-621.8	8,847	-2,800	-1,808	-1,256
Capital Expenditures	-3,404	-3,087	-1,045	-636.78	-847.71	-813.43
Free Cash Flow	-2,421	-3,709	7,802	-3,437	-2,656	-2,069
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	34.72%	32.23%	36.80%	29.37%	28.43%	30.98%
Operating Margin	3.33%	3.74%	10.54%	-14.71%	-9.56%	-14.76%
Pretax Margin	-6.27%	-15.12%	24.99%	-13.46%	-18.79%	-16.55%
Profit Margin	-4.87%	-13.74%	22.31%	-9.33%	-16.37%	-12.44%
FCF Margin	-4.57%	-7.07%	13.27%	-8.06%	-6.67%	-5.77%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	20.39	-	-	-
P/FCF Ratio	-	-	34.28	-	-	-
PS Ratio	12.65	9.66	4.55	6.89	11.21	15.30